Alexandria Real Estate Equities, Inc. (ARE) Down 6.1% — Should I Convert Back to Cash?

Key Points


  • ARE fell 6.07% to $54.61 from $58.14 previous trading day
  • Weiss Ratings assigns D (Sell)
  • Dividend yield is 8.05%

Alexandria Real Estate Equities, Inc. (ARE) is under pressure, sliding 6.07% in the latest session to close at $54.61, retreating from the prior close of $58.14 and losing $3.53 in market value per share. The stock continues to lose ground relative to its own recent history, now sitting sharply below its 52-week peak of $105.14 set on March 10, 2025. At current levels, shares are trading roughly 48% under that high-water mark, underscoring how far sentiment has retreated over the past year and how firmly the name remains in a downtrend within its 52-week range of $44.10 to $105.14.

Trading activity picked up alongside the decline, with volume at 3,014,846 shares, running above the 90-day average of 2,718,480. That heavier turnover on a down day points to more decisive selling pressure rather than a quiet drift lower. The stock is now hovering closer to the lower end of its 52-week band, reinforcing the picture of a name facing ongoing headwinds rather than one merely consolidating after prior gains. Within the broader real estate-related group, peers such as Crown Castle Inc. (CCI), Lineage, Inc. (LINE), and Fermi Inc. (FRMI) have also seen bouts of weakness recently, but ARE’s sharp drop and deep discount to its 52-week high stand out, highlighting how aggressively the stock has been repriced and how much ground would need to be recovered before any sustained uptrend could be established.


Why Alexandria Real Estate Equities, Inc. Price is Moving Lower

Weakness in ARE is largely tied to mounting fundamental and sector headwinds rather than any single company-specific catalyst. The stock has been drifting lower within the upper-$50s despite a lack of fresh announcements, reflecting sustained pressure on office-oriented and specialized REITs as investors reassess risk in higher-for-longer interest rate environments. Recent trading around $57–$58, including a -1.26% decline over the past week, fits into a broader downtrend from the 52-week high as the market discounts REITs with more challenged earnings profiles and sensitivity to financing costs.

Fundamentals are adding to the negative bias. Alexandria’s latest quarter revenue slipped to about $728.9 million from $735.9 million previously, a -0.9% sequential decline that extends a -5.2% year-over-year contraction. That topline erosion is compounded by a deeply negative profit margin of roughly -47%, signaling that operating and non-operating costs are weighing heavily on results. A reported EPS of -$8.44 underscores profitability concerns and makes the stock’s normalized P/E near 25.8 look demanding relative to shrinking revenues and losses. Against this backdrop, the broader equity REIT group — including names such as Crown Castle, Lineage, and Fermi — has been under pressure, with investors rotating toward less cyclical or more cash-flow-stable assets. Together, these sector and company-specific headwinds are keeping a lid on sentiment for Alexandria and contributing to continued downside risk in the share price.


What is the Alexandria Real Estate Equities, Inc. Rating - Should I Sell?

Weiss Ratings assigns ARE a D rating. Current recommendation is Sell. The stock was downgraded on 7/22/2025, signaling a deteriorating risk/reward profile that investors should treat with caution. A D rating means Alexandria Real Estate Equities, Inc. has been an underperformer versus alternatives with similar risk, and the overall picture skews toward capital risk rather than opportunity.

The most troubling component is the Very Weak Total Return Index, which captures how poorly shareholders have been rewarded relative to the risks taken. That concern is reinforced by the Weak Volatility Index, indicating unfavorable risk-adjusted performance rather than simply “normal” price swings. Even though the Dividend Index is Good, that income stream has not been enough to offset losses or justify the downside investors have faced.

Fundamentals raise additional red flags. The Weak Growth Index aligns with declining top-line momentum, while the company’s profit margin sits deep in negative territory at -47.38%. A negative forward P/E near -6.9 further reflects expectations for continued earnings pressure. The Efficiency Index is only Fair, meaning management’s use of capital is not strong enough to counterbalance these weaknesses, even though the balance sheet appears solid under an Excellent Solvency Index.

Within real estate peers, ARE’s D rating puts it in the same challenged camp as Crown Castle Inc. (CCI, D) and Lineage, Inc. (LINE, D), and only marginally ahead of Fermi Inc. (FRMI, E+). In this context, ARE does not stand out as a relative safe haven in a tough group; instead, it sits among multiple names where risk has outweighed reward.


About Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. (ARE) is a specialized real estate investment trust focused on life science, agtech and technology campuses. Founded in 1994, the company concentrates on owning, operating and developing large-scale, lab-ready properties explicitly built for biotechnology, pharmaceutical, and related research tenants. Its portfolio centers on so‑called “Megacampus” environments, which cluster multiple buildings, tenants and supporting infrastructure into dense, purpose-built research ecosystems. These properties are concentrated in major U.S. life science hubs such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, the Research Triangle and New York City, giving the company heavy geographic exposure to a limited set of expensive coastal markets.

The REIT’s business model revolves around leasing highly specialized laboratory and office space, which typically requires substantial upfront development costs, intensive capital expenditures and ongoing technical upkeep. Alexandria emphasizes long-duration leases with tenants in the life sciences value chain, but the niche focus also concentrates risk in a single industry that is vulnerable to funding cycles, regulatory shifts and drug development setbacks. Its heavy commitment to large collaborative campuses reduces flexibility to repurpose space for other sectors, limiting optionality if life science demand weakens in key clusters. The company positions itself as a “mission-driven” provider of critical infrastructure for innovation, yet its reliance on complex, highly tailored properties and a narrow tenant base makes it less diversified than many other equity REITs that operate across broader property types or regions.


Investor Outlook

With Alexandria Real Estate Equities, Inc. (ARE) carrying a D (Sell) Weiss Rating, investors may want to exercise caution and closely monitor how company-specific fundamentals interact with broader real estate market conditions. Watch for shifts in capital markets, refinancing costs, and sentiment toward specialized property operators, as these factors could either deepen or alleviate current risk-reward concerns. See full rankings of all D-rated Real Estate stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
NVDA NASDAQ $191.13
B
AAPL NASDAQ $259.48
B
MSFT NASDAQ $430.29
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $119.14
B
Top Financial Stocks
See All »
B
B
JPM NYSE $305.89
B
V NYSE $321.83
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $1,037.15
B
JNJ NYSE $227.25
B
AMGN NASDAQ $341.88
Top Real Estate Stocks
See All »
B
WELL NYSE $188.36
B
PLD NYSE $130.56